View more on these topics

FSA confident that life offices can take strain

The FSA has moved to reassure investors and advisers that life companies are capable of withstanding the stresses of plummeting stockmarkets.

But while the regulator says the companies can cope with further big falls, it would not give a figure as to the size of fall they could withstand.

In the progress report from the Tiner Project, the FSA reveals that the implementation of the new regulatory regime for insurers is an immediate priority. It has recruited 35 industry specialists as well as transferring senior staff to the project.

Many life companies are believed to have projected that FTSE levels would be around 5,000 by year-end but it closed at 3,787 on Tuesday.

FSA managing director John Tiner says: “On the basis of our work so far, it is fair to say the survey revealed that, on a realistic basis, life offices have significant ability to withstand further large falls in equity values from the level at which the exercise was commissioned – the FTSE100 at around 4,000.”

ABI director general Mary Francis says: “We are pleased the FSA has confirmed its confidence in the financial strength of life offices. We believe the FSA should press on with its review of realistic liabilities so that more accurate market numbers can be used in the near term for regulatory purposes.”

Cazalet Financial Consulting principal Ned Cazalet says: “The risk controls and internal analytics of the life companies have left a lot to be desired. They got away with it when they were awash with money from the stockmarkets in the 80s and 90s. There is a big difference between being able to withstand falls and being in good shape.”


Roger Ramsden

Roger Ramsden cannot be accused of merely dipping his toe in the water in his first foray into financial services. As Prudential marketing director, he plans to spend£20m on a relaunch of one of the UK&#39s biggest brands.He joined Pru a year ago after seven years at supermarket Safeway and last month launched the Plan […]

BBB £20m share issue to finance major deals

Berkeley Berry Birch is issuing over 27 million new shares to raise £20m to fund a string of large-scale acquisitions and infrastructure improvements.The group, which has 645 registered individuals and a turnover of £55m, plans to spend £16.2m on buying a number of national and regi-onal IFAs on the basis of one-third cash and two-thirds […]

The relevance graveyard

Increasingly, individuals with occupational pensions are transferring to personal pensions to take advantage of the flexibility available with future funding and drawdown.There is quite often a need to take benefits from a pension plan, particularly tax-free cash, without wishing to retire. A personal pension is the only vehicle that will allow this flexibility.But tax-free cash […]

Threadneedle eyes up health stocks

THREADNEEDLE INVESTMENTS THREADNEEDLE GLOBAL HEALTHCARE FUND Type: Oeic Aim: Growth by investing in pharmaceutical companies, biotechnology, healthcare providers, medical supply companies and producers of advanced medical devices Minimum investment: Lump sum £2,000 Investment split: Pharmaceuticals 55.5%, healthcare 14%, biotechnology 9.5%, medical technology 7%, medical supplies 8.5%, cash 5.5% Isa link: Yes Pep transfers: Yes Charges: […]


News and expert analysis straight to your inbox

Sign up


    Leave a comment


    Why register with Money Marketing ?

    Providing trusted insight for professional advisers.  Since 1985 Money Marketing has helped promote and analyse the financial adviser community in the UK and continues to be the trusted industry brand for independent insight and advice.

    News & analysis delivered directly to your inbox
    Register today to receive our range of news alerts including daily and weekly briefings

    Money Marketing Events
    Be the first to hear about our industry leading conferences, awards, roundtables and more.

    Research and insight
    Take part in and see the results of Money Marketing's flagship investigations into industry trends.

    Have your say
    Only registered users can post comments. As the voice of the adviser community, our content generates robust debate. Sign up today and make your voice heard.

    Register now

    Having problems?

    Contact us on +44 (0)20 7292 3712

    Lines are open Monday to Friday 9:00am -5.00pm